Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis.

Ninomiya K, Oze I, Kato Y, Kubo T, Ichihara E, Rai K, Ohashi K, Kozuki T, Tabata M, Maeda Y, Kiura K, Hotta K.

Acta Oncol. 2019 Nov 29:1-8. doi: 10.1080/0284186X.2019.1695062. [Epub ahead of print]

PMID:
31782328
2.

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis.

Mitani S, Kadowaki S, Oze I, Masuishi T, Narita Y, Bando H, Oonishi S, Hirayama Y, Tanaka T, Tajika M, Koide Y, Kodaira T, Abe T, Muro K.

Cancer Med. 2019 Nov 15. doi: 10.1002/cam4.2688. [Epub ahead of print]

3.

The interaction between ABCA1 polymorphism and physical activity on the HDL-cholesterol levels in a Japanese population.

Nishida Y, Hachiya T, Hara M, Shimanoe C, Tanaka K, Sutoh Y, Shimizu A, Hishida A, Tsukamoto M, Kadomatsu Y, Oze I, Koyanagi YN, Kuriyama N, Koyama T, Ibusuki R, Takezaki T, Ikezaki H, Furusyo N, Takashima N, Kadota A, Uemura H, Katsuura-Kamano S, Suzuki S, Nakagawa-Senda H, Kuriki K, Mikami H, Nakamura Y, Momozawa Y, Kubo M, Nakatochi M, Naito M, Wakai K.

J Lipid Res. 2019 Nov 6. pii: jlr.P091546. doi: 10.1194/jlr.P091546. [Epub ahead of print]

4.

Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406.

Makimoto G, Hotta K, Oze I, Ninomiya K, Nakanishi M, Hara N, Kano H, Watanabe H, Hata Y, Nishii K, Nakasuka T, Itano J, Ninomiya T, Kubo T, Ohashi K, Ichihara E, Minami D, Sato A, Tabata M, Maeda Y, Kiura K.

Acta Oncol. 2019 Oct 25:1-5. doi: 10.1080/0284186X.2019.1679880. [Epub ahead of print] No abstract available.

PMID:
31650873
5.

Combined effect of weight gain within normal weight range and parental hypertension on the prevalence of hypertension; from the J-MICC Study.

Okada R, Kadomatsu Y, Tsukamoto M, Sasakabe T, Kawai S, Tamura T, Hishida A, Ikezaki H, Furusyo N, Tanaka K, Hara M, Suzuki S, Watanabe M, Takezaki T, Nishimoto D, Matsui D, Watanabe I, Kuriki K, Takashima N, Nakamura Y, Katsuura-Kamano S, Arisawa K, Mikami H, Nakamura Y, Oze I, Koyanagi YN, Naito M, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.

J Hum Hypertens. 2019 Sep 3. doi: 10.1038/s41371-019-0230-y. [Epub ahead of print]

PMID:
31481698
6.

Revisit of an unanswered question by pooled analysis of eight cohort studies in Japan: Does cigarette smoking and alcohol drinking have interaction for the risk of esophageal cancer?

Oze I, Charvat H, Matsuo K, Ito H, Tamakoshi A, Nagata C, Wada K, Sugawara Y, Sawada N, Yamaji T, Naito M, Tanaka K, Shimazu T, Mizoue T, Tsugane S, Inoue M.

Cancer Med. 2019 Oct;8(14):6414-6425. doi: 10.1002/cam4.2514. Epub 2019 Sep 1.

7.

Association of BMI, Smoking, and Alcohol with Multiple Myeloma Mortality in Asians: A Pooled Analysis of More than 800,000 Participants in the Asia Cohort Consortium.

Ugai T, Ito H, Oze I, Saito E, Rahman MS, Boffetta P, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Koh WP, Gao YT, Sadakane A, Tsuji I, Park SK, Nagata C, You SL, Pednekar MS, Tsugane S, Cai H, Yuan JM, Xiang YB, Ozasa K, Tomata Y, Kanemura S, Sugawara Y, Wada K, Chen CJ, Yoo KY, Chia KS, Ahsan H, Zheng W, Inoue M, Kang D, Potter J, Matsuo K.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1861-1867. doi: 10.1158/1055-9965.EPI-19-0389. Epub 2019 Aug 9.

PMID:
31399476
8.

Alcohol drinking and bladder cancer risk from a pooled analysis of ten cohort studies in Japan.

Masaoka H, Matsuo K, Oze I, Ito H, Naito M, Wada K, Nagata C, Nakayama T, Kitamura Y, Sadakane A, Tamakoshi A, Tsuji I, Sugawara Y, Sawada N, Mizoue T, Inoue M, Tanaka K, Tsugane S, Shimazu T.

J Epidemiol. 2019 Jun 15. doi: 10.2188/jea.JE20190014. [Epub ahead of print]

9.

Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.

Ishikura N, Usui Y, Ito H, Kasugai Y, Oze I, Kato S, Yatabe Y, Nakamura S, Matsuo K.

Ann Hematol. 2019 Aug;98(8):1981-1987. doi: 10.1007/s00277-019-03721-y. Epub 2019 Jun 8.

PMID:
31177299
10.

Associations of Nutrient Patterns with the Prevalence of Metabolic Syndrome: Results from the Baseline Data of the Japan Multi-Institutional Collaborative Cohort Study.

Iwasaki Y, Arisawa K, Katsuura-Kamano S, Uemura H, Tsukamoto M, Kadomatsu Y, Okada R, Hishida A, Tanaka K, Hara M, Takezaki T, Shimatani K, Ozaki E, Koyama T, Suzuki S, Nakagawa-Senda H, Kuriki K, Miyagawa N, Kadota A, Ikezaki H, Furusyo N, Oze I, Ito H, Mikami H, Nakamura Y, Wakai K.

Nutrients. 2019 Apr 30;11(5). pii: E990. doi: 10.3390/nu11050990.

11.

Physician requests by patients with malignant pleural mesothelioma in Japan.

Nagamatsu Y, Oze I, Aoe K, Hotta K, Kato K, Nakagawa J, Hara K, Kishimoto T, Fujimoto N.

BMC Cancer. 2019 Apr 25;19(1):383. doi: 10.1186/s12885-019-5591-7.

12.

Independent relationships of daily life activity and leisure-time exercise with metabolic syndrome and its traits in the general Japanese population.

Uemura H, Katsuura-Kamano S, Iwasaki Y, Arisawa K, Hishida A, Okada R, Tamura T, Kubo Y, Ito H, Oze I, Shimanoe C, Nishida Y, Nakamura Y, Takashima N, Suzuki S, Nakagawa-Senda H, Nishimoto D, Takezaki T, Mikami H, Nakamura Y, Furusyo N, Ikezaki H, Ozaki E, Koyama T, Kuriki K, Endoh K, Naito M, Wakai K; Japan Multi-institutional Collaborative Cohort (J-MICC) Study Group.

Endocrine. 2019 Jun;64(3):552-563. doi: 10.1007/s12020-019-01926-9. Epub 2019 Apr 22.

PMID:
31011988
13.

Networks for early career epidemiologists around the world: the current status and future directions.

Kuwahara K, Kiyohara K, Kikuchi H, Villalonga-Olives E, Brewer N, Aman-Oloniyo A, Aggarwal P, Restrepo-Méndez MC, Oze I.

Int J Epidemiol. 2019 Jun 1;48(3):1021-1023. doi: 10.1093/ije/dyz074. No abstract available.

PMID:
31006016
14.

Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.

Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.

Commun Biol. 2019 Apr 8;2:115. doi: 10.1038/s42003-019-0339-0. eCollection 2019.

15.

A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.

Harada D, Kozuki T, Nogami N, Bessho A, Hosokawa S, Fukamatsu N, Hotta K, Ohashi K, Kubo T, Yoshioka H, Yokoyama T, Sone N, Kuyama S, Kudo K, Yasugi M, Takigawa N, Oze I, Kiura K.

Asia Pac J Clin Oncol. 2019 Aug;15(4):250-256. doi: 10.1111/ajco.13147. Epub 2019 Apr 1.

16.

Genome-wide association meta-analysis and Mendelian randomization analysis confirm the influence of ALDH2 on sleep durationin the Japanese population.

Nishiyama T, Nakatochi M, Goto A, Iwasaki M, Hachiya T, Sutoh Y, Shimizu A, Wang C, Tanaka H, Watanabe M, Hosono A, Tamai Y, Yamada T, Yamaji T, Sawada N, Fukumoto K, Otsuka K, Tanno K, Tomita H, Kojima K, Nagasaki M, Hozawa A, Hishida A, Sasakabe T, Nishida Y, Hara M, Ito H, Oze I, Nakamura Y, Mikami H, Ibusuki R, Takezaki T, Koyama T, Kuriyama N, Endoh K, Kuriki K, Turin TC, Naoyuki T, Katsuura-Kamano S, Uemura H, Okada R, Kawai S, Naito M, Momozawa Y, Kubo M, Sasaki M, Yamamoto M, Tsugane S, Wakai K, Suzuki S.

Sleep. 2019 Jun 11;42(6). pii: zsz046. doi: 10.1093/sleep/zsz046.

PMID:
30810208
17.

GWAS analysis reveals a significant contribution of PSCA to the risk of Heliobacter pylori-induced gastric atrophy.

Hishida A, Ugai T, Fujii R, Nakatochi M, Wu MC, Ito H, Oze I, Tajika M, Niwa Y, Nishiyama T, Nakagawa-Senda H, Suzuki S, Koyama T, Matsui D, Watanabe Y, Kawaguchi T, Matsuda F, Momozawa Y, Kubo M, Naito M, Matsuo K, Wakai K.

Carcinogenesis. 2019 Jul 4;40(5):661-668. doi: 10.1093/carcin/bgz016.

PMID:
30753327
18.

Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.

Lu Y, Kweon SS, Tanikawa C, Jia WH, Xiang YB, Cai Q, Zeng C, Schmit SL, Shin A, Matsuo K, Jee SH, Kim DH, Kim J, Wen W, Shi J, Guo X, Li B, Wang N, Zhang B, Li X, Shin MH, Li HL, Ren Z, Oh JH, Oze I, Ahn YO, Jung KJ, Conti DV, Schumacher FR, Rennert G, Jenkins MA, Campbell PT, Hoffmeister M, Casey G, Gruber SB, Gao J, Gao YT, Pan ZZ, Kamatani Y, Zeng YX, Shu XO, Long J, Matsuda K, Zheng W.

Gastroenterology. 2019 Apr;156(5):1455-1466. doi: 10.1053/j.gastro.2018.11.066. Epub 2018 Dec 6.

PMID:
30529582
19.

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.

Ninomiya T, Ishikawa N, Inoue K, Kubo T, Yasugi M, Shibayama T, Maeda T, Fujitaka K, Kodani M, Yokoyama T, Kuyama S, Ochi N, Ueda Y, Miyoshi S, Kozuki T, Amano Y, Kubota T, Sugimoto K, Bessho A, Ishii T, Watanabe K, Oze I, Hotta K, Kiura K.

Clin Lung Cancer. 2019 Mar;20(2):134-138. doi: 10.1016/j.cllc.2018.10.008. Epub 2018 Nov 1.

PMID:
30514667
20.

Association of exposure level to passive smoking with hypertension among lifetime nonsmokers in Japan: a cross-sectional study.

Tamura T, Kadomatsu Y, Tsukamoto M, Okada R, Sasakabe T, Kawai S, Hishida A, Hara M, Tanaka K, Shimoshikiryo I, Takezaki T, Watanabe I, Matsui D, Nishiyama T, Suzuki S, Endoh K, Kuriki K, Kita Y, Katsuura-Kamano S, Arisawa K, Ikezaki H, Furusyo N, Koyanagi YN, Oze I, Nakamura Y, Mikami H, Naito M, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study.

Medicine (Baltimore). 2018 Nov;97(48):e13241. doi: 10.1097/MD.0000000000013241.

21.

Trends in Small-Cell Lung Cancer Survival in 1993-2006 Based on Population-Based Cancer Registry Data in Japan.

Oze I, Ito H, Nishino Y, Hattori M, Nakayama T, Miyashiro I, Matsuo K, Ito Y.

J Epidemiol. 2019 Sep 5;29(9):347-353. doi: 10.2188/jea.JE20180112. Epub 2018 Nov 17.

22.

Perceived Barriers to Career Progression Among Early-Career Epidemiologists: Report of a Workshop at the 22nd World Congress of Epidemiology.

Kikuchi H, Kuwahara K, Kiyohara K, Villalonga-Olives E, Brewer N, Aman-Oloniyo A, Aggarwal P, Restrepo-Méndez MC, Hara A, Kakizaki M, Akiyama Y, Onishi K, Kurotani K, Haseda M, Amagasa S, Oze I.

J Epidemiol. 2019 Jan 5;29(1):38-41. doi: 10.2188/jea.JE20180184. Epub 2018 Oct 6. No abstract available.

23.

Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21.

Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi A, Momozawa Y, Hirata M, Fuse N, Takai-Igarashi T, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Hishida A, Wakai K, Furusyo N, Murakami Y, Nakamura Y, Imoto I, Inazawa J, Oze I, Sato N, Tanioka F, Sugimura H, Hirose H, Yoshida T, Matsuo K, Kubo M, Matsuda K.

Cancer Sci. 2018 Dec;109(12):4015-4024. doi: 10.1111/cas.13815. Epub 2018 Oct 31.

24.

Association of genetic risk score and chronic kidney disease in a Japanese population.

Fujii R, Hishida A, Nakatochi M, Furusyo N, Murata M, Tanaka K, Shimanoe C, Suzuki S, Watanabe M, Kuriyama N, Koyama T, Takezaki T, Shimoshikiryo I, Arisawa K, Katsuura-Kamano S, Takashima N, Turin TC, Kuriki K, Endoh K, Mikami H, Nakamura Y, Oze I, Ito H, Kubo M, Momozawa Y, Kondo T, Naito M, Wakai K.

Nephrology (Carlton). 2019 Jun;24(6):670-673. doi: 10.1111/nep.13479. Epub 2019 Apr 29.

PMID:
30146708
25.

Genomewide Association Study of Leisure-Time Exercise Behavior in Japanese Adults.

Hara M, Hachiya T, Sutoh Y, Matsuo K, Nishida Y, Shimanoe C, Tanaka K, Shimizu A, Ohnaka K, Kawaguchi T, Oze I, Matsuda F, Ito H, Kawai S, Hishida A, Okada R, Sasakabe T, Hirata A, Ibusuki R, Nindita Y, Furusyo N, Ikezaki H, Kuriyama N, Ozaki E, Mikami H, Nakamura Y, Suzuki S, Hosono A, Katsuura-Kamano S, Arisawa K, Kuriki K, Endoh K, Takashima N, Kadota A, Nakatochi M, Momozawa Y, Kubo M, Naito M, Wakai K.

Med Sci Sports Exerc. 2018 Dec;50(12):2433-2441. doi: 10.1249/MSS.0000000000001712.

26.

Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol.

Makimoto G, Ichihara E, Hotta K, Ninomiya K, Oze I, Minami D, Ninomiya T, Kubo T, Ohashi K, Tabata M, Maeda Y, Kiura K.

Acta Med Okayama. 2018 Jun;72(3):319-323. doi: 10.18926/AMO/56080.

27.

A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.

Fujimoto N, Aoe K, Kozuki T, Oze I, Kato K, Kishimoto T, Hotta K.

Clin Lung Cancer. 2018 Sep;19(5):e705-e707. doi: 10.1016/j.cllc.2018.05.001. Epub 2018 May 9.

28.

Dietary inflammatory index and risk of upper aerodigestive tract cancer in Japanese adults.

Abe M, Shivappa N, Ito H, Oze I, Abe T, Shimizu Y, Hasegawa Y, Kiyohara C, Nomura M, Ogawa Y, Hebert JR, Matsuo K.

Oncotarget. 2018 May 8;9(35):24028-24040. doi: 10.18632/oncotarget.25288. eCollection 2018 May 8.

29.

Genome-Wide Association Study of Renal Function Traits: Results from the Japan Multi-Institutional Collaborative Cohort Study.

Hishida A, Nakatochi M, Akiyama M, Kamatani Y, Nishiyama T, Ito H, Oze I, Nishida Y, Hara M, Takashima N, Turin TC, Watanabe M, Suzuki S, Ibusuki R, Shimoshikiryo I, Nakamura Y, Mikami H, Ikezaki H, Furusyo N, Kuriki K, Endoh K, Koyama T, Matsui D, Uemura H, Arisawa K, Sasakabe T, Okada R, Kawai S, Naito M, Momozawa Y, Kubo M, Wakai K; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.

Am J Nephrol. 2018;47(5):304-316. doi: 10.1159/000488946. Epub 2018 May 18.

PMID:
29779033
30.

Association between ALDH2 and ADH1B polymorphisms, alcohol drinking and gastric cancer: a replication and mediation analysis.

Ishioka K, Masaoka H, Ito H, Oze I, Ito S, Tajika M, Shimizu Y, Niwa Y, Nakamura S, Matsuo K.

Gastric Cancer. 2018 Nov;21(6):936-945. doi: 10.1007/s10120-018-0823-0. Epub 2018 Apr 3.

PMID:
29616362
31.

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.

Nagamatsu Y, Oze I, Aoe K, Hotta K, Kato K, Nakagawa J, Hara K, Kishimoto T, Fujimoto N.

BMC Cancer. 2018 Mar 27;18(1):350. doi: 10.1186/s12885-018-4293-x.

32.

Changes in self-efficacy associated with success in quitting smoking in participants in Japanese smoking cessation therapy.

Taniguchi C, Tanaka H, Saka H, Oze I, Tachibana K, Nozaki Y, Suzuki Y, Sakakibara H.

Int J Nurs Pract. 2018 Aug;24(4):e12647. doi: 10.1111/ijn.12647. Epub 2018 Mar 23.

PMID:
29573128
33.

Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients.

Narita Y, Kadowaki S, Oze I, Kito Y, Kawakami T, Machida N, Taniguchi H, Ura T, Ando M, Ito S, Tajika M, Yatabe Y, Yasui H, Muro K.

J Gastrointest Oncol. 2018 Feb;9(1):52-63. doi: 10.21037/jgo.2017.11.08.

34.

Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.

Adachi Y, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Oze I, Iwata H.

Breast Cancer. 2018 Sep;25(5):560-565. doi: 10.1007/s12282-018-0852-x. Epub 2018 Mar 13.

PMID:
29536376
35.

Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.

Shiga Y, Akiyama M, Nishiguchi KM, Sato K, Shimozawa N, Takahashi A, Momozawa Y, Hirata M, Matsuda K, Yamaji T, Iwasaki M, Tsugane S, Oze I, Mikami H, Naito M, Wakai K, Yoshikawa M, Miyake M, Yamashiro K; Japan Glaucoma Society Omics Group (JGS-OG), Kashiwagi K, Iwata T, Mabuchi F, Takamoto M, Ozaki M, Kawase K, Aihara M, Araie M, Yamamoto T, Kiuchi Y, Nakamura M, Ikeda Y, Sonoda KH, Ishibashi T, Nitta K, Iwase A, Shirato S, Oka Y, Satoh M, Sasaki M, Fuse N, Suzuki Y, Cheng CY, Khor CC, Baskaran M, Perera S, Aung T, Vithana EN, Cooke Bailey JN, Kang JH, Pasquale LR, Haines JL; NEIGHBORHOOD Consortium, Wiggs JL, Burdon KP, Gharahkhani P, Hewitt AW, Mackey DA, MacGregor S, Craig JE, Allingham RR, Hauser M, Ashaye A, Budenz DL, Akafo S, Williams SEI, Kamatani Y, Nakazawa T, Kubo M.

Hum Mol Genet. 2018 Apr 15;27(8):1486-1496. doi: 10.1093/hmg/ddy053.

36.

Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in Japan.

Kashino I, Akter S, Mizoue T, Sawada N, Kotemori A, Matsuo K, Oze I, Ito H, Naito M, Nakayama T, Kitamura Y, Tamakoshi A, Tsuji I, Sugawara Y, Inoue M, Nagata C, Sadakane A, Tanaka K, Tsugane S, Shimazu T; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan.

Int J Cancer. 2018 Jul 15;143(2):307-316. doi: 10.1002/ijc.31320. Epub 2018 Mar 8.

37.

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery.

Makimoto G, Kubo T, Oze I, Ohashi K, Hotta K, Tabata M, Soh J, Toyooka S, Katsui K, Takigawa N, Tanimoto M, Kiura K.

Jpn J Clin Oncol. 2018 Mar 1;48(3):287-290. doi: 10.1093/jjco/hyy003.

PMID:
29409038
38.

A genome-wide association study in the Japanese population identifies the 12q24 locus for habitual coffee consumption: The J-MICC Study.

Nakagawa-Senda H, Hachiya T, Shimizu A, Hosono S, Oze I, Watanabe M, Matsuo K, Ito H, Hara M, Nishida Y, Endoh K, Kuriki K, Katsuura-Kamano S, Arisawa K, Nindita Y, Ibusuki R, Suzuki S, Hosono A, Mikami H, Nakamura Y, Takashima N, Nakamura Y, Kuriyama N, Ozaki E, Furusyo N, Ikezaki H, Nakatochi M, Sasakabe T, Kawai S, Okada R, Hishida A, Naito M, Wakai K, Momozawa Y, Kubo M, Tanaka H.

Sci Rep. 2018 Jan 24;8(1):1493. doi: 10.1038/s41598-018-19914-w.

39.

Body-Mass Index and Pancreatic Cancer Incidence: A Pooled Analysis of Nine Population-Based Cohort Studies With More Than 340,000 Japanese Subjects.

Koyanagi YN, Matsuo K, Ito H, Tamakoshi A, Sugawara Y, Hidaka A, Wada K, Oze I, Kitamura Y, Liu R, Mizoue T, Sawada N, Nagata C, Wakai K, Nakayama T, Sadakane A, Tanaka K, Inoue M, Tsugane S, Sasazuki S.

J Epidemiol. 2018 May 5;28(5):245-252. doi: 10.2188/jea.JE20160193. Epub 2017 Dec 9.

40.

Modification of the Associations of Alcohol Intake With Serum Low-Density Lipoprotein Cholesterol and Triglycerides by ALDH2 and ADH1B Polymorphisms in Japanese Men.

Sasakabe T, Wakai K, Kawai S, Hishida A, Naito M, Suzuki S, Nindita Y, Arisawa K, Kita Y, Hara M, Kuriyama N, Hirata A, Mikami H, Oze I, Kubo M, Tanaka H, Hamajima N.

J Epidemiol. 2018 Apr 5;28(4):185-193. doi: 10.2188/jea.JE20160189. Epub 2017 Nov 25.

41.

Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993-2000 to 2001-2006 in Japan.

Inoue S, Hosono S, Ito H, Oze I, Nishino Y, Hattori M, Matsuda T, Miyashiro I, Nakayama T, Mizuno M, Matsuo K, Kato K, Tanaka H, Ito Y; J-CANSIS Research Group.

J Epidemiol. 2018 Feb 5;28(2):75-80. doi: 10.2188/jea.JE20170008. Epub 2017 Nov 4.

42.

Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Taniguchi A, Miyahara N, Oda N, Morichika D, Ichihara E, Oze I, Tanimoto Y, Ichikawa H, Fujii U, Tanimoto M, Kanehiro A, Kiura K.

Acta Med Okayama. 2017 Oct;71(5):453-457. doi: 10.18926/AMO/55446.

43.

Genetic Variants of RAMP2 and CLR are Associated with Stroke.

Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Takeshita W, Iwai K, Watanabe Y, Nakatochi M, Shimanoe C, Tanaka K, Oze I, Ito H, Uemura H, Katsuura-Kamano S, Ibusuki R, Shimoshikiryo I, Takashima N, Kadota A, Kawai S, Sasakabe T, Okada R, Hishida A, Naito M, Kuriki K, Endoh K, Furusyo N, Ikezaki H, Suzuki S, Hosono A, Mikami H, Nakamura Y, Kubo M, Wakai K.

J Atheroscler Thromb. 2017 Dec 1;24(12):1267-1281. doi: 10.5551/jat.41517. Epub 2017 Sep 14.

44.

Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.

Sawabe M, Ito H, Takahara T, Oze I, Kawakita D, Yatabe Y, Hasegawa Y, Murakami S, Matsuo K.

Cancer. 2018 Jan 1;124(1):118-124. doi: 10.1002/cncr.30957. Epub 2017 Sep 7.

45.

The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese.

Abe M, Ito H, Oze I, Nomura M, Ogawa Y, Matsuo K.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2481-2492. doi: 10.1007/s00432-017-2505-4. Epub 2017 Aug 28.

PMID:
28849422
46.

Smoking and subsequent risk of acute myeloid leukaemia: A pooled analysis of 9 cohort studies in Japan.

Ugai T, Matsuo K, Oze I, Ito H, Wakai K, Wada K, Nagata C, Nakayama T, Liu R, Kitamura Y, Tamakoshi A, Tsuji I, Sugawara Y, Sawada N, Sadakane A, Tanaka K, Mizoue T, Inoue M, Tsugane S, Shimazu T; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan.

Hematol Oncol. 2018 Feb;36(1):262-268. doi: 10.1002/hon.2457. Epub 2017 Jul 6.

PMID:
28681440
47.

Coffee consumption and the risk of colorectal cancer by anatomical subsite in Japan: Results from the HERPACC studies.

Nakagawa-Senda H, Ito H, Hosono S, Oze I, Tanaka H, Matsuo K.

Int J Cancer. 2017 Jul 15;141(2):298-308. doi: 10.1002/ijc.30746. Epub 2017 May 8.

48.

Cognitive, behavioural and psychosocial factors associated with successful and maintained quit smoking status among patients who received smoking cessation intervention with nurses' counselling.

Taniguchi C, Tanaka H, Saka H, Oze I, Tachibana K, Nozaki Y, Suzuki Y, Sakakibara H.

J Adv Nurs. 2017 Jul;73(7):1681-1695. doi: 10.1111/jan.13258. Epub 2017 Feb 17.

PMID:
28103398
49.

Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.

Oze I, Shimada S, Nagasaki H, Akiyama Y, Watanabe M, Yatabe Y, Matsuo K, Yuasa Y.

J Cancer Res Clin Oncol. 2017 Mar;143(3):551-554. doi: 10.1007/s00432-016-2316-z. Epub 2016 Dec 1.

PMID:
27909811
50.

Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.

Ninomiya K, Ichihara E, Hotta K, Sone N, Murakami T, Harada D, Oze I, Kubo T, Tanaka H, Kuyama S, Kishino D, Bessho A, Harita S, Katsui K, Tanimoto M, Kiura K.

Clin Lung Cancer. 2017 Mar;18(2):245-249. doi: 10.1016/j.cllc.2016.08.001. Epub 2016 Oct 19.

PMID:
27847247

Supplemental Content

Support Center